Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.24 | 2.16 | 11.37 | 0.99 | 4.74 | 1.28 | 1.35 | 1.67 | 0.00 | 0.00 | 0.88 | 0.00 |
| Expenses | 3.10 | 2.07 | 11.24 | 0.89 | 4.54 | 1.03 | 1.84 | 1.53 | 0.04 | 0.04 | 0.97 | 0.01 |
| Operating Profit | 0.14 | 0.09 | 0.13 | 0.10 | 0.20 | 0.25 | -0.49 | 0.14 | -0.04 | -0.04 | -0.09 | -0.01 |
| OPM % | 4.32% | 4.17% | 1.14% | 10.10% | 4.22% | 19.53% | -36.30% | 8.38% | -10.23% | |||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.14 | 0.09 | 0.13 | 0.10 | 0.20 | 0.25 | -0.49 | 0.14 | -0.04 | -0.04 | -0.09 | -0.01 |
| Tax % | 0.00% | 22.22% | 53.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 0.14 | 0.08 | 0.06 | 0.10 | 0.20 | 0.25 | -0.49 | 0.14 | -0.04 | -0.04 | -0.09 | -0.01 |
| EPS in Rs | 0.12 | 0.07 | 0.05 | 0.09 | 0.08 | 0.10 | -0.19 | 0.05 | -0.02 | -0.02 | -0.03 | -0.00 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.05 | 0.15 | 1.04 | 0.45 | 0.00 | 0.13 | 0.48 | 1.25 | 13.53 | 8.35 | 2.55 | 0.88 |
| Expenses | 0.05 | 0.04 | 0.04 | 0.34 | 0.03 | 0.13 | 0.39 | 1.00 | 13.30 | 8.29 | 2.59 | 1.06 |
| Operating Profit | 0.00 | 0.11 | 1.00 | 0.11 | -0.03 | 0.00 | 0.09 | 0.25 | 0.23 | 0.06 | -0.04 | -0.18 |
| OPM % | 0.00% | 73.33% | 96.15% | 24.44% | 0.00% | 18.75% | 20.00% | 1.70% | 0.72% | -1.57% | -20.45% | |
| Other Income | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | 0.11 | 1.00 | 0.12 | -0.03 | 0.00 | 0.09 | 0.25 | 0.23 | 0.06 | -0.04 | -0.18 |
| Tax % | 27.27% | 30.00% | 41.67% | 166.67% | 22.22% | 28.00% | 30.43% | 33.33% | 0.00% | |||
| Net Profit | 0.00 | 0.08 | 0.70 | 0.07 | -0.08 | 0.00 | 0.07 | 0.18 | 0.15 | 0.04 | -0.04 | -0.18 |
| EPS in Rs | 0.00 | 0.07 | 0.62 | 0.06 | -0.07 | 0.00 | 0.06 | 0.16 | 0.13 | 0.02 | -0.02 | -0.07 |
| Dividend Payout % | 0.00% | 0.00% | 81.21% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 48% | 81% | 27% | -90% | ||
| Compounded Profit Growth | % | % | % | -280% | ||
| Stock Price CAGR | % | -37% | -33% | -53% | ||
| Return on Equity | 1% | 0% | 0% | 0% |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 25.78 | 25.78 |
| Reserves | 0.00 | 0.01 | 0.64 | 0.64 | 0.61 | 0.61 | 0.68 | 0.86 | 1.01 | 6.09 | 4.95 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.82 | 0.68 | 0.36 | 0.16 | 0.15 | 0.07 | 0.28 | 0.38 |
| Other Liabilities | 0.03 | 0.13 | 0.42 | 0.19 | 0.05 | 0.04 | 0.08 | 1.13 | 4.32 | 6.37 | 5.73 |
| Total Liabilities | 11.40 | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 | 38.52 | 36.84 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
| CWIP | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21.12 | 21.12 |
| Other Assets | 8.11 | 8.22 | 9.14 | 9.73 | 9.42 | 9.09 | 8.99 | 10.21 | 13.47 | 14.11 | 12.42 |
| Total Assets | 11.40 | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 | 38.52 | 36.84 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.04 | 0.21 | -0.04 | -0.86 | 0.15 | 0.32 | 0.18 | 0.21 | -0.12 | 1.30 | 0.03 |
| Cash from Investing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | -21.11 | -0.13 |
| Cash from Financing Activity | 0.00 | -0.07 | -0.07 | 0.75 | -0.14 | -0.32 | 0.00 | -0.02 | -0.09 | 19.67 | 0.09 |
| Net Cash Flow | 0.04 | 0.15 | -0.11 | -0.11 | 0.01 | 0.00 | 0.17 | 0.19 | -0.21 | -0.14 | -0.01 |
| Free Cash Flow | 0.04 | 0.21 | -0.04 | -0.86 | 0.15 | 0.32 | 0.17 | 0.21 | -0.12 | 1.30 | 0.01 |
| CFO/OP | 218% | 26% | -736% | -500% | 222% | 112% | -22% | 2,200% | -75% |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 357.98 | 632.67 | 1,460.00 | 372.60 | 183.96 | 131.38 | 247.41 | 735.73 | |
| Inventory Days | 821.25 | 547.50 | 381.59 | 4.61 | 8.40 | 0.00 | |||||
| Days Payable | 0.00 | 0.00 | 423.07 | 117.92 | 270.17 | ||||||
| Cash Conversion Cycle | 821.25 | 547.50 | 357.98 | 632.67 | 1,460.00 | 372.60 | 142.48 | 18.07 | -14.36 | 735.73 | |
| Working Capital Days | 7,665.00 | 2,238.67 | 572.07 | 681.33 | 3,818.46 | 357.40 | 134.32 | 49.10 | 14.86 | -131.69 | |
| ROCE % | 0.97% | 8.55% | 0.97% | -0.24% | 0.00% | 0.73% | 2.03% | 1.85% | 0.27% | -0.13% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 21.22% | 21.22% | 21.22% | 21.22% | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% |
| Public | 78.77% | 78.78% | 78.78% | 78.78% | 90.64% | 90.64% | 90.64% | 90.64% | 90.63% | 90.64% | 90.64% | 90.65% |
| No. of Shareholders | 6,400 | 7,167 | 7,824 | 7,824 | 8,503 | 9,097 | 9,097 | 8,737 | 9,541 | 10,166 | 11,027 | 11,352 |
Fundamentals
Market Cap₹ 7.45 Cr.
Current Price₹ 2.89
Book Value₹ 11.9
ROCE-0.13 %
ROE-0.13 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-90%
Compounded Profit Growth (TTM)-280%
Standalone figures.
Valuation
Market capRs 7 Cr
Enterprise valueRs 7 Cr
Price to book0.22x
Price to sales2.60x
EV / sales2.73x
Price to cash flow220.84x
Earnings yield-2.72%
P/E, 3-year average516.98x
P/B, 3-year average1.07x
P/E, 5-year average302.54x
P/B, 5-year average0.86x
Profitability
Operating margin (excl. other income)-1.57%
Operating margin (incl. other income)-1.57%
EBITDA margin-7.06%
Pre-tax margin-7.06%
Net profit margin-7.06%
ROE-0.13%
ROCE-0.13%
ROA-0.11%
ROE, 3-year average0.42%
ROCE, 3-year average0.67%
ROA, 3-year average0.34%
ROE, 5-year average0.67%
ROCE, 5-year average0.95%
ROA, 5-year average0.60%
ROIC (approx.)-0.58%
Growth
Sales growth (latest year)-69.46%
Profit growth (latest year)-200.00%
Sales CAGR, 3 years26.83%
Sales CAGR, 5 years81.35%
Profit growth YoY (latest quarter)-107.14%
Per share
EPS (TTM)Rs -0.07
EPS (latest quarter)Rs -0.00
EPS, 3-year averageRs 0.07
EPS, 5-year averageRs 0.09
Book value per shareRs 11.92
Sales per shareRs 0.99
Cash flow per shareRs 0.01
Free cash flow per shareRs 0.00
Efficiency
Asset turnover0.07x
Fixed asset turnover255.00x
Debtor days736 days
Debtors turnover0.50x
Creditor days270 days
Cash conversion cycle736 days
Working capital days-132 days
Leverage
Total debtRs 0 Cr
Cash and bankRs 0 Cr
Net debtRs 0 Cr
Debt to equity0.01x
Owners' fund to total sources83.41%
Debt to assets1.03%
Cash flow
Cash from Operating Activity (latest year)Rs 0 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs 0 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs 0 Cr
FCFE (approx.: FCF + change in debt)Rs 0 Cr
Cash from ops / profit, 5 years4.00x
Sales to cash flow85.00x
Statement figures
Net sales (TTM)Rs 3 Cr
Net sales (latest year)Rs 3 Cr
Operating profit excl. other income (latest year)Rs -0 Cr
Operating profit (latest quarter)Rs -0 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest year)Rs -0 Cr
Net profit (latest quarter)Rs -0 Cr
Cost of goods sold (latest year)Rs 2 Cr
Total expenditure (latest year)Rs 3 Cr
Total income (latest year)Rs 3 Cr
Share capitalRs 26 Cr
ReservesRs 5 Cr
Shareholders' fundsRs 31 Cr
Total assetsRs 37 Cr
Net blockRs 0 Cr
Capital work in progressRs 3 Cr
InvestmentsRs 21 Cr
ReceivablesRs 5 Cr
Other liabilitiesRs 6 Cr
Shares outstanding (crore)2.58
Ownership
Promoter holding9.36% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 0.22 is the lowest in 5.7 years (median 1.96).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 543207 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -17.9% | -2.8% | -15.1 pts |
| 1 month | -26.4% | -6.8% | -19.6 pts |
| 3 months | -31.5% | -7.6% | -23.8 pts |
| 3 years | -73.0% | +14.2% | -87.2 pts |
| 5 years | -91.4% | +27.9% | -119.3 pts |
Red flags
F-score 3 of 8| explain | Receivables outrunning sales Receivables grew -9% vs sales -69% in 2026 |
| explain | Share dilution Share count up 0% in a year, 126% in three |
| explain | Debt up, profit down Borrowings up 36% while net profit fell in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹0 Cr -100.0% vs Jun 2025.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| UPL Ltd | 45,402 | 23.0 | 10.1 % |
| P I Industries Ltd | 34,725 | 32.2 | 15.0 % |
| Sumitomo Chemical India Ltd | 21,521 | 37.7 | 23.5 % |
| Bayer CropScience Ltd | 16,191 | 22.1 | 29.1 % |
| Sharda Cropchem Ltd | 6,509 | 10.4 | 30.2 % |
| Dhanuka Agritech Ltd | 4,148 | 15.5 | 23.8 % |
| Rallis India Ltd | 3,882 | 17.0 | 14.1 % |
| Bhagiradha Chemicals & Industries Ltd | 3,128 | 114 | 4.53 % |
| NACL Industries Ltd | 3,101 | 120 | 8.13 % |
| GSP Crop Science Ltd | 2,198 | 21.0 | 18.9 % |
| Insecticides India Ltd | 1,706 | 13.6 | 15.8 % |
| Bharat Rasayan Ltd | 1,673 | 12.0 | 16.1 % |
| Astec Lifesciences Ltd | 1,552 | -5.44 % | |
| India Pesticides Ltd | 1,533 | 14.2 | 16.6 % |
| Meghmani Organics Ltd | 1,458 | 22.7 | 6.71 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Natural Biocon (India) Ltd?
Natural Biocon (India) Ltd (543207) has a market capitalisation of Rs 7.45 Cr. at the 2026-10-01 close.
What were Natural Biocon (India) Ltd's latest quarterly results?
In the Jun 2026 quarter, Natural Biocon (India) Ltd sales was Rs 0 Cr (-100.0% vs Jun 2025) with a net loss of Rs 0 Cr.